Redhill expands manufacturing for COVID-19 candidate
Company signs deals with two specialist pharmaceutical manufacturers
Read More
Tag: opaganib
MHRA issues consent for RedHill Bioharma’s Yeliva trial
The study will assess the potential of the drug in patients hospitalised with severe SARS-CoV-2 infection and pneumonia
Read More
- Strong clinical data for Breye lead asset danegaptide
- EHP Awards triumph
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
